| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 720203 | 1151011027 | PREGABALINA SANDOZ 75 MG CAPSULAS DURAS | PREGABALINA SANDOZ 75 MG CAPSULAS DURAS, 56 cápsulas | 75 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151011027/1151011027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151011027/1151011027_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2018-03-12 | 1 | 1 | 1 | 2018-03-13 | 2018-03-12 | 0 | 2018-10-11 | View Edit Delete | ||||||||||||
| 726249 | 1151011040 | PREGABALINA SANDOZ 100 MG CAPSULAS DURAS EFG | PREGABALINA SANDOZ 100 MG CAPSULAS DURAS EFG, 84 cápsulas | 100 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151011040/1151011040_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151011040/1151011040_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2019-07-16 | 1 | 1 | 1 | 2019-07-17 | 2019-07-16 | 0 | 2020-01-14 | View Edit Delete | ||||||||||||
| 720204 | 1151011050 | PREGABALINA SANDOZ 150 MG CAPSULAS DURAS EFG | PREGABALINA SANDOZ 150 MG CAPSULAS DURAS EFG, 56 cápsulas | 150 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151011050/1151011050_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151011050/1151011050_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2018-03-12 | 1 | 1 | 1 | 2018-03-13 | 2018-03-12 | 0 | 2018-06-13 | View Edit Delete | ||||||||||||
| 769910 | 1151011061 | PREGABALINA SANDOZ 200 MG CAPSULAS DURAS EFG | PREGABALINA SANDOZ 200 MG CAPSULAS DURAS EFG, 84 cápsulas | En revisión | 5 | 84 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151011061/1151011061_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151011061/1151011061_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2019-07-16 | 1 | 1 | 1 | 2019-07-17 | 2026-02-13 | 0 | 2026-06-12 | View Edit Delete | ||||||||||||||
| 720205 | 1151011077 | PREGABALINA SANDOZ 300 MG CAPSULAS DURAS EFG | PREGABALINA SANDOZ 300 MG CAPSULAS DURAS EFG, 56 cápsulas | 300 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151011077/1151011077_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151011077/1151011077_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2018-03-12 | 1 | 1 | 1 | 2018-03-13 | 2018-03-12 | 0 | 2018-05-15 | View Edit Delete | ||||||||||||
| 706935 | 1151014001 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 10 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001/1151014001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001/1151014001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2015-07-06 | 1 | 1 | 1 | 2015-07-06 | 2015-07-06 | 1 | 2015-12-17 | View Edit Delete | ||||||||||||
| 728143 | 1151014001IP | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 10 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001IP/1151014001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001IP/1151014001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | ABACUS MEDICINE A/S | 2020-03-04 | 1 | 1 | 1 | 2020-03-05 | 2020-03-04 | 1 | 2020-05-18 | View Edit Delete | ||||||||||||
| 731263 | 1151014001IP1 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 10 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001IP1/1151014001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001IP1/1151014001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | MELYFARMA S.L. | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 768403 | 1151014001IP2 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial 4 ml | 10 mg/ml | 45 | 1 | 34 | 1 vial 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001IP2/1151014001IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001IP2/1151014001IP2_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | ORIFARM A/S | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 706934 | 1151014002 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002/1151014002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002/1151014002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2015-07-06 | 1 | 1 | 1 | 2015-07-06 | 2015-07-06 | 1 | 2015-12-17 | View Edit Delete | ||||||||||||
| 727329 | 1151014002IP | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP/1151014002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP/1151014002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | ABACUS MEDICINE A/S | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-03-31 | View Edit Delete | ||||||||||||
| 731262 | 1151014002IP1 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP1/1151014002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP1/1151014002IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | MELYFARMA S.L. | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 768402 | 1151014002IP2 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP2/1151014002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP2/1151014002IP2_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | ORIFARM A/S | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 707491 | 1151016002 | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 140 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151016002/1151016002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151016002/1151016002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7884 | AMGEN S.A. | 2015-08-19 | 1 | 1 | 1 | 2015-08-19 | 2015-08-19 | 1 | 2016-01-27 | View Edit Delete | ||||||||||||
| 710049 | 1151016003 | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas | 140 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151016003/1151016003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151016003/1151016003_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7884 | AMGEN S.A. | 2016-02-24 | 1 | 1 | 1 | 2016-02-24 | 2016-02-24 | 1 | 2016-06-01 | View Edit Delete | ||||||||||||
| 765050 | 1151016003IP | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas | 140 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151016003IP/1151016003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151016003IP/1151016003IP_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7884 | ABACUS MEDICINE A/S | 2024-05-30 | 1 | 1 | 1 | 2024-05-31 | 2024-05-30 | 1 | 2024-07-20 | View Edit Delete | ||||||||||||
| 731456 | 1151019005 | BORTEZOMIB ACCORD 2,5 MG/ML SOLUCION INYECTABLE | BORTEZOMIB ACCORD 2,5 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml | 2,5 mg inyectable | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151019005/1151019005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151019005/1151019005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2021-09-17 | 1 | 1 | 1 | 2021-09-18 | 2021-09-17 | 1 | 2022-01-11 | View Edit Delete | ||||||||||||
| 731457 | 1151019005 | BORTEZOMIB ACCORD 2,5 MG/ML SOLUCION INYECTABLE | BORTEZOMIB ACCORD 2,5 MG/ML SOLUCION INYECTABLE, 1 vial de 1,4 ml | 3,5 mg inyectable | 45 | 1 | 34 | 1 vial de 1,4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151019005/1151019005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151019005/1151019005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2021-09-17 | 1 | 1 | 1 | 2021-09-18 | 2021-09-17 | 1 | 2022-01-12 | View Edit Delete | ||||||||||||
| 707419 | 1151021003 | PREGABALINA ZENTIVA 25 mg CAPSULAS DURAS EFG | PREGABALINA ZENTIVA 25 mg CAPSULAS DURAS EFG , 56 cápsulas | 25 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151021003/1151021003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151021003/1151021003_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8183 | ZENTIVA K.S. | 2015-08-14 | 1 | 1 | 1 | 2015-08-14 | 2015-08-14 | 1 | 2022-04-27 | View Edit Delete | ||||||||||||
| 731876 | 1151021008 | PREGABALINA ZENTIVA 50 MG CAPSULAS DURAS EFG | PREGABALINA ZENTIVA 50 MG CAPSULAS DURAS EFG, 56 cápsulas | 50 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151021008/1151021008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151021008/1151021008_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8183 | ZENTIVA K.S. | 2021-11-11 | 1 | 1 | 1 | 2021-11-12 | 2021-11-11 | 1 | 2022-04-27 | View Edit Delete |
Page 72 of 1035, showing 20 records out of 20697 total, starting on record 1421, ending on 1440